Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.37 |
| ▸ | ALPI | P09923 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | XIAP | P98170 | 1/20 | 0.37 |
| ▸ | TPH1 | P17752 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL3909625 | 1.00 | SLC7A5 (0.50) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL1900124 | 0.95 | SLC7A5 (0.45) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL2004299 | 0.92 | SLC7A5 (0.42) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL26977289 | 0.91 | SLC7A5 (0.60) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL8588121 | 0.91 | SLC7A5 (0.49) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL8588119 | 0.91 | SLC7A5 (0.49) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL20377367 | 0.89 | SLC7A5 (0.63) | SLC7A5ALOX15PTGS1ALPIPKM | |
| Tyrosine SCHEMBL27482098 | 0.87 | SLC7A5 (0.55) | SLC7A5ALOX15BLMPMP22KMT2A | |
| Tyrosine SCHEMBL4575526 | 0.87 | SLC7A5 (0.67) | SLC7A5ALOX15PTGS1ALPIPKM | |
| Tyrosine SCHEMBL8134263 | 0.87 | SLC7A5 (0.67) | SLC7A5ALOX15BLMPMP22KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1861497-A4 | PROTEIN AND ITS USE IN DIAGNOSING ALZHEIMER'S DISEASE | NYMOX CORP (CA) | 2009-01-28 | — | — | EP | disclosed |
| WO-2008014603-A2 | PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS | NYMOX CORPORATION (CA) | 2008-02-07 | — | — | WO | disclosed |
| EP-1861497-A1 | PROTEIN AND ITS USE IN DIAGNOSING ALZHEIMER'S DISEASE | NYMOX CORPORATION (CA) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006089422-A1 | PROTEIN AND ITS USE IN DIAGNOSING ALZHEIMER'S DISEASE | NYMOX CORPORATION (CA) | 2006-08-31 | — | — | WO | disclosed |
| EP-1626984-A1 | SPHERON COMPONENTS USEFUL IN DETERMINING COMPOUNDS CAPABLE OF TREATING SYMPTOMS OF ALZHEIMER'S DISEASE | Nymox Pharmaceutical Corporation (CA) | 2006-02-22 | — | — | EP | disclosed |
| WO-2004104029-A1 | SPHERON COMPONENTS USEFUL IN DETERMINING COMPOUNDS CAPABLE OF TREATING SYMPTOMS OF ALZHEIMER’S DISEASE | NYMOX PHARMACEUTICAL CORPORATION (CA) | 2004-12-02 | — | — | WO | disclosed |
| EP-1481007-A2 | SPHERON COMPONENTS USEFUL IN DETERMINING COMPOUNDS CAPABLE OF TREATING SYMPTOMS OF ALZHEIMER'S DISEASE, TREATMENTS AND ANIMAL MODELS PRODUCED THEREFROM | Nymox Corporation (CA) | 2004-12-01 | — | — | EP | disclosed |
| EP-1417227-A2 | PEPTIDES EEFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS | Nymox Corporation (CA) | 2004-05-12 | — | — | EP | disclosed |
| EP-1417228-A2 | PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS | NYMOX CORPORATION (CA) | 2004-05-12 | — | — | EP | disclosed |
| EP-1392347-A2 | METHOD OF PREVENTING CELL DEATH USING SEGMENTS OF NEURAL THREAD PROTEINS | NYMOX CORPORATION (CA) | 2004-03-03 | — | — | EP | disclosed |
| US-6165753-A | Cyclin E genes and proteins | AMGEN INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1045907-A1 | DKR POLYPEPTIDES | Amgen Inc. (US) | 2000-10-25 | — | — | EP | disclosed |
| WO-2000058479-A1 | BETA SECRETASE GENES AND POLYPEPTIDES | AMGEN INC. (US) | 2000-10-05 | — | — | WO | disclosed |
| WO-2000046240-A2 | POLYPEPTIDES INVOLVED IN IMMUNE RESPONSE | AMGEN INC. (US) | 2000-08-10 | — | — | WO | disclosed |
| WO-2000044898-A2 | NOVEL AGOUTI AND AGOUTI-RELATED PEPTIDE ANALOGS | AMGEN INC. (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000034475-A2 | GRNF4, A GDNF-RELATED NEUROTROPHIC FACTOR | AMGEN INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000018914-A2 | NOVEL DKR POLYPEPTIDES | AMGEN INC. (US) | 2000-04-06 | — | — | WO | disclosed |
| US-6034230-A | MODULATE INFLAMMATORY HEART DISEASE. | AMGEN CANADA INC. (CA) | 2000-03-07 | — | — | US | disclosed |
| WO-2000009692-A1 | NOVEL PEPTIDES CAPABLE OF MODULATING INFLAMMATORY HEART DISEASE | AMGEN CANADA INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| WO-1999063089-A1 | CYCLIN E2 GENES AND PROTEINS | AMGEN INC. (US) | 1999-12-09 | — | — | WO | disclosed |